Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06895460 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)

StatusNot Yet Recruiting
PhasePhase 3
Started2025-06-20
View on ClinicalTrials.gov ↗

Amendment history

2025-06-03
Study Status, Eligibility v1
Start date2025-03-20→2025-06-20
Eligibility criteria+369 characters
[...] uncontrolled asthma (according to the 2024 GINA guidelines-Asthmaasthma Controlcontrol Classificationlevel Criteriaclassification criteria, patients with partially controlled and uncontrolled asthma); Within the past 6 months, at least one of the following p [...] illingness to participate in the study. Exclusion Criteria: Patients with a history of severe asthma (according to the definition in the Guidelines for the Prevention and Treatment of Bronchial Asthma (2024 Edition)); Patients in the acute exacerbation phase who may require intravenous/oral corticosteroids; Patients with rheumatology and i [...] [...]
2025-03-19
Original filing
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial on the Treatment of Bronchial Asthma with Budesonide Formoterol Combined with Immune Modulators (Staphylococcus and Neisseria Tablets)
Trial Details
NCT Number NCT06895460
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions Bronchial Asthma
Enrollment 198 participants
Start Date 2025-06-20
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-05